Prasugrel 5 mg

DRUG3 trials

Sponsors

Dong-A University, University of Florida, J.P.S Henriques

Conditions

Acute Coronary SyndromeCoronary Arterial Disease (CAD)Coronary Artery DiseasePercutaneous Coronary Intervention (PCI)

Phase 3

Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)

CompletedNCT02944123

Dong-A UniversityAcute Coronary Syndrome

Start: 2016-09-30End: 2020-06-30Updated: 2020-08-20

Phase 4

Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study

RecruitingNCT06821191

University of FloridaCoronary Artery Disease

Start: 2025-03-10End: 2027-01-07Target: 78Updated: 2025-04-15

Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)

RecruitingNCT06916520

J.P.S HenriquesCoronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI)

Start: 2025-11-13End: 2027-04-01Target: 300Updated: 2026-03-04